Other

Number of commercialized products

Alnylam Pharmaceuticals Number of commercialized products remained flat by 0.0% to $4.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $4.00 to $4.00.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2022
Last reportedQ1 2026
Metric ID: other_number_of_commercialized_products

Historical Data

13 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value3344444444444
QoQ Change+0.0%+33.3%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%
YoY Change+33.3%+33.3%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%
Range34
CAGR+10.1%
Avg YoY Growth+6.7%
Median YoY Growth+0.0%
Current Streak12+ quarters growth

Frequently Asked Questions

What is Alnylam Pharmaceuticals's number of commercialized products?
Alnylam Pharmaceuticals (ALNY) reported number of commercialized products of $4.00 in Q1 2026.
How has Alnylam Pharmaceuticals's number of commercialized products changed year-over-year?
Alnylam Pharmaceuticals's number of commercialized products decreased by 0.0% year-over-year, from $4.00 to $4.00.